We have developed and validated a methodology for determining the antibody composition of the polyclonal serum response after immunization. Pepsin-digested serum IgGs were subjected to standard antigen-affinity chromatography, and resulting elution, wash, and flow-through fractions were analyzed by bottom-up, liquid chromatography-high-resolution tandem mass spectrometry. Identification of individual monoclonal antibodies required the generation of a database of IgG variable gene (V-gene) sequences constructed by NextGen sequencing of mature B cells. Antibody V-gene sequences are characterized by short complementarity determining regions (CDRs) of high diversity adjacent to framework regions shared across thousands of IgGs, greatly complicating the identification of antigen-specific IgGs from proteomically observed peptides. By mapping peptides marking unique V H CDRH3 sequences, we identified a set of V-genes heavily enriched in the affinity chromatography elution, constituting the serum polyclonal response. After booster immunization in a rabbit, we find that the antigenspecific serum immune response is oligoclonal, comprising antibodies encoding 34 different CDRH3s that group into 30 distinct antibody V H clonotypes. Of these 34 CDRH3s, 12 account for ∼60% of the antigen-specific CDRH3 peptide mass spectral counts. For comparison, antibodies with 18 different CDRH3s (12 clonotypes) were represented in the antigen-specific IgG fraction from an unimmunized rabbit that fortuitously displayed a moderate titer for BSA. Proteomically identified antibodies were synthesized and shown to display subnanomolar affinities. The ability to deconvolute the polyclonal serum response is likely to be of key importance for analyzing antibody responses after vaccination and for more completely understanding adaptive immune responses in health and disease.
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antibody proteomics | antibody repertoire | serum immunoprofiling | B-cell response | humoral response T he first Nobel Prize in Medicine was awarded to Emil von Behring, who in collaboration with Kitasato Shibasaburo and Paul Ehrlich discovered serum antitoxins (1, 2). Remarkably, after more than 100 y of intense research in immunology, little is known about the clonality, relative concentrations, and binding properties of the monoclonal antibodies that constitute the antigen-specific Ig pool in serum.
At steady state, circulating antibodies are produced by terminally differentiated B lymphocytes (plasma cells) within the bone marrow, and thus cannot be accessed in living individuals (3). Although recent single B-cell cloning methods (4, 5) have led to the identification of peripheral antigen-specific B memory and/or antibody-secreting cells (plasmablasts), it is generally unknown whether the Igs encoded by peripheral blood B cells correspond to the antibodies present in circulation and especially whether they are present at physiologically relevant levels (i.e., at serum concentrations above K D corresponding to >1 μg/mL for an average affinity of individual antibodies of 5 nM).
The proteomic deconvolution of serum Igs presents two major technical challenges: first, antibody genes in antigen stimulated B-lymphocytes are not simply encoded in the germline but are extensively diversified by somatic recombination, revision, and/or mutation. Therefore, the sequence database required for the interpretation of mass spectra is not available a priori (6, 7) and is completely different for each individual. Second, the antigenspecific antibody pool comprises a wide variety of Igs that display very high levels of amino acid identity within the framework regions. As a result, standard approaches for proteomic analysis by MS are confounded by this exceptionally high rate of identical sequence shared among Ig-derived peptides, which greatly complicates the task of confidently identifying individual variable (V) genes through peptide mapping. Advancements in sequencing and MS technologies have shown some success against these challenges. MS-based de novo sequencing approaches have been used for the identification of purified monoclonal antibodies (8).
More recently the identification of a limited subset of antigenspecific antibodies in serum after very stringent enrichment to reduce the complexity of the antigen-specific polyclonal antibody pool to a limited set of Igs from humans and animals was reported (9-12). However, because of the inherent difficulties associated with the proteomic analysis of complex mixtures of antibodies, these studies had focused on the identification of only a small subset of the antigen-specific serum IgGs present in a fraction isolated after stringent affinity chromatography.
In contrast, complete understanding of how B-cell differentiation ultimately shapes humoral immunity requires addressing the more difficult problem of how to deconvolute the entire repertoire of antigen-specific antibodies in serum or in other secretions.
Here we describe the proteomic deconvolution of the serumderived antigen-specific polyclonal antibody pool by combining NextGen sequencing of the immunoglobulin heavy chain variable region (V H gene) repertoire with liquid chromatographyhigh-resolution tandem mass spectrometry (LC-MS/MS) (Fig. 1) . Proteomic identifications of unique V H -derived peptides (overwhelmingly from the CDR3 region of the V H sequences) were used to determine the V H repertoire of circulating antigen-specific antibodies, and identified V H genes were shown to encode antibodies with subnanomolar antigen affinity.
Results
Overview of Experimental Approach. The first step for serum antibody deconvolution is the high-throughput sequencing of B lymphocyte cDNAs to generate a database of class-switched antibody V H sequences in a particular individual (Fig. 1) . In parallel, full-length IgGs are purified by protein A affinity chromatography and treated with pepsin to prepare F(ab) 2 fragments. Antigen-specific F(ab) 2 fragments are then isolated by affinity chromatography on immobilized antigen. Bound antibodies are eluted using standard immunoaffinity chromatography conditions (elution with pH 2.7 buffer), and the flow-through and the wash buffer from the column are also collected to identify weakly antigen-binding antibodies. The F(ab) 2 fragments are proteolytically digested, and the resulting peptides are resolved by high-resolution LC-MS/MS analysis on an Orbitrap Velos (Thermo Scientific). To ensure comprehensive coverage of the antibody repertoire, we performed three replicate injections per sample, using LC elution with a long, shallow gradient of 5-40% acetonitrile over 245 min, yielding an average of >100,000 MS2 fragmentation spectra per sample. Peptides found to be enriched >10-fold in the elution fraction compared with wash and flow-through were considered as corresponding to IgGs exhibiting a high degree of antigen specificity.
By far the highest diversity in antibodies occurs within the CDR3 region of the V H (CDRH3), which is overwhelmingly responsible for antigen recognition (13) (Fig. 2A) . Composed of the V(D)J join with its inherent junctional diversity, the CDRH3 specifies the V H clonotype. The V H clonotype is defined as the group of V H sequences that share germ-line V and J segments, have identical CDRH3 lengths, and exhibit greater than 80% amino acid identity in the CDRH3 sequences (14, 15) . The V H clonotype is an important immunological concept because it accounts for antibodies that likely originate from a single B-cell lineage and may provide insight on the evolution of the antigenspecific response of that lineage. Therefore, we focused here on the high-confidence identification of CDRH3 peptides and of the corresponding clonotypes. As shown later, unique peptides derived from non-CDRH3 regions of Igs (i.e., from peptides containing all or portions of framework 1-3, CDR1, or CDR2 sequences) and corresponding to a single V gene in the database make only a minor contribution to the determination of the repertoire in immunized rabbits (contributing to <15% of the total identified clonotypes). Once the CDRH3s have been identified, the full-length sequences of corresponding V H genes are determined from the NextGen V H DNA database.
To generate antibodies, proteomically identified V H sequences must be paired with the V L genes. We therefore synthesized V H domain DNAs and used these to construct phage displayed scFv libraries comprising the V L cDNA repertoire. Functional scFv antibodies were isolated after two to three rounds of phage panning. Putative pairings of V H and V L genes were then expressed recombinantly as full-size IgGs in mammalian cells and isolated to characterize their antigen affinity and functionality.
V Gene Repertoire Analysis. Preliminary studies in mice revealed that the methodology described in Fig. 1 was able to successfully identify abundant, antigen-specific IgGs in the serum of immunized mice. However, the small amount of serum that is obtained from mice at killing (0.8-1.5 mL) resulted in low counts of Vgene informative peptides and poor MS identification statistics. Larger amounts of serum can easily be obtained from humans, as well as other comparatively larger animals such as rabbits, an animal model that has been used extensively for immunological studies for nearly a century. For the present study, a New Zealand white rabbit (Oryctolagus cuniculus) was immunized with Concholepas concholepas hemocyanin (CCH) in complete Freund's adjuvant (CFA), boosted with antigen in incomplete FA and killed 1 wk after the final boost (CCH rabbit). Additionally, to further validate our approach we performed serum IgG deconvolution on an unimmunized rabbit that, surprisingly, was found to exhibit a titer toward BSA (BSA rabbit; this observation occurred fortuitously because BSA was used as the generic blocking agent in our ELISA protocol). Unlike the BSA rabbit, the animal immunized with CCH did not exhibit any titer toward BSA. We prepared RNA samples from total peripheral B Fig. 1 . Schematic of the workflow for serum Ig deconvolution. (Left) V gene repertoire sequencing pipeline: total RNA from desired B-cell subpopulations is reverse transcribed and amplified by 5′ RACE with IgG-specific (V H ) or Ig κ /Ig λ -specific (V L ) primers and sequenced by Roche 454 sequencing. Reads are processed bioinformatically to obtain a database of unique V genes and their relative transcript abundances. The V gene database is used to interpret the MS spectra. (Right) F(ab) 2 purification and proteomic pipeline: F(ab) 2 fragments from IgG are prepared and subjected to antigen-affinity chromatography. Proteins in the eluent, flow-through, and wash buffer are denatured, alkylated, proteolyzed, and resolved by high-resolution LC-MS/MS. Full-length V genes containing the identified iCDR3 peptides are then determined from the repertoire database. (Lower) Antibody production and validation: synthetic V H genes are assembled into an scFv library using the V L cDNA, then antigen-specific antibodies are isolated by two to three rounds of phage panning and characterized for antigen affinity.
cells (PBCs), total bone marrow cells, and CD138
+ bone marrow plasma cells (BM-PCs) isolated by magnetic sorting. First-strand cDNAs were generated using an oligo(dT) primer, and doublestranded products were amplified via 5′ RACE (16) using primers complementary to rabbit IgG CH1 (SI Appendix, Table S1 ). DNA amplification by 5′ RACE was preferable to using published FR1 and J region-specific primers designed for combinatorial library construction (17) because existing 5′ primer sets have not been validated for quantitative V gene amplification. In contrast, 5′ RACE circumvents the need for V gene-specific primers and provides a more accurate representation of the repertoire by avoiding biases introduced by the selection of PCR primer sets. V gene cDNA was sequenced using Roche 454 GS FLX Titanium (SI Appendix, Table S2 ). Germ-line V and J use were determined (Fig.  2B ) as previously described (18). To reduce the impact of sequencing errors, the V H and V L protein sequence databases were compiled using sequences that occurred at n ≥ 2 reads.
Consistent with earlier reports of limited germ-line V gene diversity in rabbits (19, 20) , we found that 89% of the V H genes in the IgG repertoire (CCH rabbit) were derived from only two germ-line V genes (1S40 and 1S45), and an overwhelming 75% contained the IGHJ4 segment. V gene and J gene use was highly similar in BM-PCs and PBCs. In the BSA rabbit, 86% of the V H sequences were derived from 1S44, 1S45, and 1S40, whereas 55% contained the IGHJ4 and 28% contained the IGHJ2 J-segment (SI Appendix, Fig. S1 ). CDRH3 lengths in the class-switched IgG repertoire of an immunized rabbit were longer than in immunized mice (SI Appendix, Fig. S2 ) (21). The rabbit class-switched V genes displayed a bimodal distribution of amino acid substitutions relative to the germline, with one peak centered at 9-aa substitutions, slightly higher than in the mouse, and a second peak at 24-to 25-aa substitutions (SI Appendix, Fig. S3 ). Because gene conversion is an important mechanism for Ig diversification in the rabbit (22), it cannot be ascertained whether the highly mutated V gene population resulted from activation-induced deaminase (AID) mutagenesis or from recombination events with V pseudogenes.
MS Proteomic Detection of Ig-Identifying Peptides. IgG antibodies from a 2.5 mL rabbit serum sample were purified by Protein A affinity chromatography. F(ab) 2 fragments were prepared by pepsin digestion and purified by affinity chromatography on immobilized CCH or BSA yielding ∼0.7 and 0.2 mg of highpurity F(ab) 2 protein, respectively (>95% pure as determined by SDS/PAGE; typical results shown in SI Appendix, Fig. S4 ). The protein in the flow-through and wash fractions was also collected for LC-MS/MS analysis. The individual fractions were denatured, reduced, and alkylated with iodoacetamide to modify Cys residues before digestion with trypsin (SI Appendix, SI Materials and Methods). In silico analysis of the V gene database showed that digestion with trypsin should generate peptide fragments with enough coverage of the CDRH3 region and of lengths appropriate for MS detection to uniquely identify 91.4% of the putative antibody clones (SI Appendix, Fig. S5 ). Cleavage by chymotrypsin added less than 3% in observable V H clone coverage, and a similar effect was calculated for other cleavagespecific proteases. This slight potential gain in coverage was diminished when potential missed cleavages were considered.
Peptides were analyzed by nanospray LC-MS/MS, and collected spectra were searched by Sequest against an in-house NextGen rabbit V H +V L sequence database (containing sequences with n ≥ 2 reads) concatenated with the rabbit full protein-coding sequence database (OryCun2) and MaxQuant contaminants database (23, 24) . Postsearch processing by the Percolator algorithm (25) generated a dataset of peptide-spectrum matches (PSMs) with an expected false-discovery rate <1%. False identifications were further controlled at the peptide level by accepting only those peptide identifications for which all PSMs exhibited an average deviation from the expected peptide mass of ≤1.5 ppm. Spectra were manually checked for consistency with the identified sequences, including the presence of modifications (static carbamidomethyl modification of Cys residues and dynamic oxidation of methionine to methionine-sulfoxide) and signature motifs such as the IGHJ-derived sequence, which gave a characteristic spectral pattern (Table 1) .
Peptides identified by MS analysis were classified according to their cooccurrence with CDRH3 sequences in the V gene DNA sequence database. Peptides that uniquely identified specific CDRH3s were defined as informative of CDRH3 (iCDRH3) peptides; in contrast, peptides mapping to multiple CDRH3 sequences were defined as noninformative (niCDRH3). iCDRH3 peptides were considered antigen-specific if the frequency of spectral counts in the affinity chromatography elution fraction was 10-fold greater than in the combined wash and flow-through fractions. More than three-quarters of all peptides containing portions of a CDRH3 sequence were found to correspond to iCDRH3s (SI Appendix, Fig. S6 ) (75% and 85% of CDRH3-derived peptides in CCH and BSA rabbits, respectively). A small fraction of upstream peptides (i.e., from CDR1 or CDR2) mapping to nondegenerate V gene sequences (all with the same CDRH3) in the database were also identified, providing additional coverage and identification of antigen-specific clonotypes. By including the information deduced from these upstream iCDRH3 peptides, the number of antigen-specific iCDRH3s in CCH rabbit serum increased from 29 to 34. An additional 25 peptides defining 83 full-length V-gene sequences were detected in the elution fraction but were overwhelmingly present in the wash and flow-through fractions (elution frequency:flowthrough + wash frequency ratio <10), indicative of very weakly binding/low-specificity and very low abundance antibodies ( Fig. 3A ; also SI Appendix, Fig. S7 for the BSA-specific iCDRH3 peptides). SI Appendix, Fig. S8 documents the high reproducibility among technical replicates. V-family and J-family gene use of full V H sequences corresponding to identified iCDRH3 peptides were found to be consistent with the germ-line gene use data obtained from 454 sequencing (Fig. 2B ) and BSA rabbits (SI Appendix, Fig. S1 ; also SI Appendix, Fig. S9 for CDRH3 statistics).
In total, our analysis of the CCH rabbit revealed that the antigen-specific polyclonal response is composed of ∼34 IgG antibodies that are classified into 30 different clonotypes [same V and J, same CDRH3 length, 80% aa homology (14, 15) ]; 4 of the 34 antibodies that constitute the majority of the antigen-specific IgG repertoire in this animal differed by only 1-3 aa and therefore corresponded to clonally related antibodies ( Fig. 3B ; also SI Appendix, Fig. S10 for BSA). The top 12 iCDRH3 peptides accounted for ∼60% of all of the antigen-specific peptide counts, suggesting that the serum response was dominated by yet a smaller set of antibodies (sequence logo shown in SI Appendix, Fig. S11 ). The BSA rabbit data revealed a more restricted response comprising 18 distinct antibodies, as shown in SI Appendix, Fig. S10 and Table S3 .
Comparison of the composition of the serum IgG response with the V gene repertoires obtained by NextGen sequencing of B cells in different compartments can provide useful insights on the dynamics of the humoral response. For example, in the CCH rabbit, 18 of 34 of the V H sequences encoding the serum antibody repertoire correspond to BM-PC sequences in the sequencing database (database comprising sequences from BM and PBCs as detailed in SI Appendix, Table S2 ). The remainder (16 of 34) of the identified serum antibody repertoire map to PBC sequences in the database. Thus, 7 d after boost immunization nearly half of the serum antibodies seem to be expressed predominantly by plasma cells that had migrated into the bone marrow.
Construction and Characterization of Serum MAbs. To evaluate whether the identified V H genes encoded proteins that recognize the antigen, it was first necessary to identify the V L domains to which they pair. The in vivo V H :V L pairing problem cannot be universally solved (i.e., for all identified V H sequences) by proteomic approaches for two reasons: (i) the abundances of V H and V L chains do not correlate because an excess of V L chains are secreted in the serum, and V H chains can pair with more than one V L ; and (ii) because of the lower sequence complexity of V L chains relative to V H , higher proportions of V L peptides share partial sequence identity, resulting in increased ambiguity in PSMs and peptide-sequence mappings. Hence, the proteomic problem of distinguishing false-positive identifications increases significantly, and the confidence in the analysis is weak. We therefore addressed the V H :V L pairing problem by synthesizing select V H genes and then performing two to three rounds of phage panning of scFv libraries constructed with amplified V L cDNA (i.e., a V L chain shuffled library for each selected V H ). Phage panning of a fixed V H with a library of V L genes is an established method for identifying functional pairs that bind antigen with high affinity (26). The V H genes corresponding to seven of the most abundant proteomically identified iCDRH3s were synthesized by automated DNA synthesis (18). In instances where more than one full-length V H gene in the database corresponded to an iCDRH3 (owing to additional somatic mutations within the V gene), the most common somatic variant was selected for synthesis. The libraries were confirmed to be of sufficient size to cover the entire V L gene repertoire deduced from DNA sequencing, as estimated by rarefaction analysis (SI Appendix, Fig. S12 ).
For the antigen-specific full-length scFvs isolated by panning (SI Appendix, Table S4 ), DNA sequencing revealed that the synthetic V H genes paired with one or, in the case of V H gene 6, two clonally related V L domains (SI Appendix, Fig. S13 ). The V H and V L genes were inserted into vectors encoding rabbit H and L chains, respectively, and cotransfected into HEK293 cells to produce the respective IgGs. The recombinant antibodies were found to display subnanomolar K D for the antigen by competitive ELISA (Fig. 4 ) and shown to be effective for iCDRH3 peptide sequences, counts of affiliated mass spectra, and their frequencies relative to all spectral counts in the eluent (in parentheses), corresponding full-length CDRH3 sequences, and numbers of somatic variants deduced from the V H DNA sequence database. BM-PC, V H genes from the bone marrow PCs; PBC, V H genes from peripheral B-cells. Percentages of spectral counts corresponding to oxidation products (oxidized L-Met) are shown in parentheses in the full CDRH3 sequences column. iCDRH3 peptides detected in the affinity chromatography eluent are marked as "E," in the wash buffer as "W," or in the flow-through as "F." *V H synthesized for phage panning and binding validation.
immunoprecipitation of CCH from mock mixtures (SI Appendix, Fig. S14 ). Certain proteomically identified V H genes (2, 5, 7) did not yield specific binders by phage panning. This is not surprising, because it is well established that recombinant rabbit antibody fragments are particularly difficult to express in bacteria (27) . Panning phage display of libraries using synthetic V H genes from the BSA library also showed significant enrichment after two rounds.
Discussion
We report a general strategy for the molecular deconvolution of the monoclonal antibodies that constitute the polyclonal response to antigen. We found that the serum IgG response in an immunized rabbit is oligoclonal, comprising 34 individual antibodies with high antigen selectivity that grouped into 30 distinct clonotypes of antigen-specific antibodies likely to have been derived from different progenitor B cells (SI Appendix, Fig. S15 ). An unimmunized animal that fortuitously had a titer to BSA contained 18 antigenspecific antibodies (12 clonotypes) .
The first step in the analysis pipeline involved the determination of the V gene repertoire using NextGen sequencing. In the rabbit we find that the class-switched repertoire is dominated by the use of two to three germ-line V H families and by two germ-line J H families [J4 and J2 in both CCH and BSA rabbits (Fig. 2B and SI Appendix, Fig. S1 )]. The analysis of the V gene repertoire further revealed that a subpopulation of rabbit V genes contains a large number of amino acid substitutions relative to the germline, likely a consequence of the gene conversion processes that occur during V gene diversification in rabbits. The deconvolution of the serum IgGs was made possible by LC/MS-MS shotgun proteomic analysis using an individually derived B-cell V gene sequence database, combined with strict filtering criteria for the confident identification of peptide sequences, including the use of a high mass accuracy filter (≤1.5 ppm). Although we have provided evidence that our analysis correctly captures the key features of the serological IgG repertoire, we do acknowledge that as a method that relies on LC-MS, it is subject to the experimental constraints of shotgun proteomic analyses (28).
Collectively, the identification of the repertoire of antigenspecific antibodies in serum leads to several interesting observations. First, the serum response in these animals seemed to be oligoclonal (i.e., neither is it highly diverse nor does it comprise only of a handful different antibodies). Second, V H use in the circulating antibodies was entirely consistent with the V H gene repertoire in the animal as determined by NextGen sequencing, highlighting the significance of the cellular repertoire in shaping humoral immunity ( Fig. 2B and SI Appendix, Fig. S1 ). Third, it is interesting that most of the antigen-specific V H clonotypes identified proteomically correspond to a single V gene or at most to only a few somatic variants. However, this may not always be the case, especially when antibodies are generated in response to persistent or recurrent infections (29-32). In those instances, detection of peptides from CDR1 and CDR2 might be used to identify the dominant somatic variant(s) in serum. Fourth, as (Table 1 ) identified in the CCH immunized rabbit. Antibodies identified using the proposed methodology ( Fig. 1) were shown to display subnanomolar affinities. The expression yield of the rabbit IgG-6 antibody in HEK-293 cells was too low for accurate quantitative affinity measurements.
expected, many of the proteomically identified CDRH3s corresponded to V H genes isolated from BM-PCs. Approximately half of the iCDRH3s, however, were found to map only to PBCs and may be derived from recently activated plasmablasts in transit to the bone marrow. We note that because the formation of plasmablasts in the course of B-cell expansion is a consequence of asymmetric division that should also give rise to B memory cells, highly exhaustive DNA sequencing of the peripheral B memory V gene repertoire should be sufficient to yield all of the Ig sequences found in circulation at steady state (33). Fifth, the CCH rabbit data revealed that two of the top ranked iCDRH3s in terms of spectral counts display evidence of oxidative modifications, as shown in Table 1 . Although it is known that amino acid oxidation can occur during sample preparation, it is tempting to speculate that the oxidative modification of certain circulating IgGs may have resulted from in vivo posttranslational modifications rather than processing artifacts, because plasma cells experience high levels of oxidative stress (34), and the t 1/2 of circulating Igs in serum is >1 wk, resulting in extensive exposure of antibodies to oxidizing conditions. L-Methionine oxidation has also been observed repeatedly in recombinantly expressed therapeutic antibodies from CHO cells (35, 36) . Additional studies will be needed to determine the extent of L-Methionine oxidation during sample processing and the frequency of in vivo modification.
At present the molecular deconvolution of antigen-specific serum antibodies requires a sample size of ∼3-5 mL of whole blood, an amount that is easily obtainable from most laboratory animals down to rats and also from humans. With further advances in the sensitivity of MS, it may prove possible to also analyze the Ig serum composition from a single mouse, including genetically homogenous transgenic animals displaying well-characterized defects in B-cell development. Importantly, the approach we have developed may be extended to the analysis of the serological response in humans after vaccination or related to pathologic states.
Materials and Methods
All materials used in this study, including vendor source are provided in SI Appendix, SI Materials and Methods.
Rabbit immunization, serum IgG isolation and sample preparation for LC-MS/MS measurements, proteomics data analysis, and all related computational analyses are described in SI Appendix, SI Materials and Methods.
Validation and characterization of proteomically identified serum antibodies including synthetic gene synthesis, recombinant IgG cloning, and ELISA methodologies are provided in detail in SI Appendix, SI Materials and Methods. 
SI Materials and Methods

Rabbit immunization and sample preparation
Rabbit CCH: A New Zealand white rabbit was immunized with 100 µg Concholepas concholepas hemocyanin (CCH, Pierce, IL, USA) in 2 ml of 1:1 saline and complete (1), with the exception that PBC's did not require red blood cell lysis after gradient centrifugation. CD138 + cells were isolated as previously described using rat anti-mouse CD138 antibody-clone 281-2 (BD Pharmingen, CA, USA), which had been shown (2) to be cross-reactive to rabbit CD138. Cell fractions 
Amplification and high-throughput sequencing of V H and V L gene repertoires
Approximately 0.5 µg of ethanol precipitated RNA was used for first-strand cDNA synthesis according to the manufacturer's protocol for 5' RACE using the SMARTer RACE cDNA Amplification kit (Clontech, CA, USA). The cDNA reaction was diluted into 100 µl of Tris-EDTA buffer and stored at -20°C. 5' RACE PCR amplification was performed on the first strand cDNA to amplify the V H repertoire with the kit-provided, 5' primer mix and 3' rabbit IgG-specific primers RIGHC1 and RIGHC2 ( Table S1 ). The rabbit V L repertoire was amplified via 5' RACE, using a 3' primer mix specific for both the V κ and V λ rabbit constant regions. The V L primer mix comprised 90% RIGκC and 10% RIG λ C (Table S1 ) to approximate known ratios of light chain isotypes in rabbits. All 454 data were first processed using the sequence quality and signal filters of the 454
Roche pipeline and then subjected to bioinformatics analysis that relied on homologies to conserved framework regions and V germline gene identification using IMGT/HighVQuest Tool (3). The numbers of full-length V sequences, unique V genes and CDRH3s are summarized in Table S2 . Additional filters were applied for full repertoire database construction as follows: (i) Length cutoff: full-length sequences were filtered by aligned amino acid lengths > 70 residues and aligned framework 4 region lengths > 2 residues;
(ii) Stop codons: aligned amino acid sequences containing stop codons were removed;
(iii) Finally for the purposes of germline VDJ, CDR3 length and amino acid composition analyses, only sequences with n≥2 reads were considered.
Protein A purification and pepsin digestion 2.5 ml of rabbit serum was diluted 4-fold in PBS and IgG proteins were purified by affinity chromatography using 2.5 ml of protein A agarose (Pierce, IL, USA) packed in an Econo-Pac chromatography column (Biorad, CA, USA). Diluted serum was recycled 6 times through the protein A affinity column in gravity mode. The column was washed with 10 column volumes (CV) of PBS and IgG was eluted using 5 CV of 100 mM glycine pH 2.7 and immediately neutralized with 1M Tris-HCl pH 8.5. IgG in the flow through, wash and elution was determined by non-reducing SDS-PAGE in 4-20% gels (Biorad, CA, USA). Protein A purified serum IgG was digested to produce F(ab) 2 fragments using immobilized pepsin (Pierce, IL, USA). Briefly, 500 µl of immobilized pepsin agarose was equilibrated with 20 mM sodium acetate, pH 4.5 mixed with approximately 10 mg of purified IgG in 1.5 ml 20 mM sodium acetate, pH 4.5. Digestion was allowed to proceed for 7 hours, shaking vigorously at 37 °C. The pepsin-agarose ! 4! beads were separated by applying the reaction solution to an Ultrafree centrifugal filter column (Millipore, MA, USA) and the degree of digestion was evaluated by nonreducing 4-20% SDS-PAGE (Fig. S4) 
Antigen enrichment
Affinity chromatography for the isolation of antigen-specific IgG-derived F(ab) for 60 min at room temperature, washed with PBS and packed into a 15 ml and 5 ml Econo-Pac chromatography column (CCH and BSA coupled beads respectively, Biorad, CA, USA). F(ab) 2 fragments were applied to the CCH and BSA affinity column in gravity mode, with the flow-through collected and reapplied to the column 5 times. The column was subsequently washed with 10 CV of PBS, eluted using 100 mM glycine pH 2.7 and immediately neutralized with 1 M Tris-HCl pH 8.5. The flow-through, wash, and elution fractions were collected for subsequent analysis.
Trypsin digestion
Trypsin digestion in the presence of TFE was carried out by as follows: Protein fractions from the affinity chromatography steps above (fractions from elution, flow through and wash buffer) were incubated at 37 °C for 60 min in a reaction solution that consisted of (final concentrations): 50% v/v TFE, 50 mM ammonium bicarbonate and 2.5 mM DTT.
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Denatured, reduced F(ab') 2 were then alkylated by incubation with 32 mM iodoacetamide (Sigma, MO, USA) for 1 hour at room temperature and quenched by addition of 7.7 mM DTT for 1 hour at room temperature. Samples were diluted with water to reach a final TFE concentration of 5% v/v. Trypsin digestion was carried out with a ratio of 1:75 trypsin:protein and incubating at 37 °C for 5 hours. Trypsin was inactivated by lowering the pH with 1% v/v formic acid.
Sample preparation for LC-MS/MS
Trypsin digested F(ab) 2 peptides were concentrated by SpeedVac centrifugation and the 
LC-MS/MS measurements
The resulting peptides from antigen enriched trypsin digested F(ab) 2 were loaded onto an Acclaim PepMap C18 Column (Dionex, IL, USA) interfaced to a Ultimate3000
RSLCnano UHPLC system (Dionex) and separated using a 5-40% acetonitrile gradient over 245 minutes. Peptides were eluted onto an LTQ Orbitrap Velos mass spectrometer (Thermo Scientific) using a Nano-spray source. The LTQ Orbitrap Velos was operated in data dependent mode with a target value of 5e5 ions for parent ion (MS1) scans collected at 60,000 resolution. Ions with charge >+1 were selected for fragmentation by collision-induced dissociation with a maximum of 20 MS2 scans per MS1. Dynamic exclusion was activated, with a 45-s exclusion time for ions selected more than twice in a 30-s window.
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Proteomics Data Analysis
The resulting spectra were searched against a protein sequence database consisting of the in-house rabbit V H and V L sequences obtained as described above, concatenated with the rabbit full protein-coding sequence database (OryCun2) and a database of common protein contaminants compiled by the Max Planck Institute of Biochemistry (www.maxquant.org). Peptide-spectrum matches were identified by SEQUEST (Proteome Discoverer 1.3, Thermo Scientific). Only V H and V L sequences with ≥2 reads were included in the search. The search specified full tryptic peptides with up to 2 missed tryptic cleavages allowed. A precursor mass tolerance of 10 ppm was used, with fragment mass tolerance set to 0.5 Da. Carbamidomethylation of cysteine residues by iodoacetamide was selected as a static modification, while oxidized methionine was allowed as a dynamic modification. Following the search, peptides were filtered using Percolator (4) through Proteome Discoverer, with an applied FDR of <1% determined against a reverse-sequence decoy database. For cases where multiple high-confidence matches were scored for the same spectrum (with maximum ΔCN of 0.05 allowed), the top-match was selected unless it showed an absolute mass error >2ppm and was superseded by a lower-ranking match with absolute mass error at least 0.5 ppm more accurate than the top-ranked match.
To control false discovery rates at the peptide level, the average mass deviation (AMD) was calculated for each set of spectra identified as the same peptide, with modifications considered as unique from unmodified peptides, and only peptide identifications with an average <1.5 ppm across all PSMs were included in the final dataset. For these purposes, all observed masses were first recalibrated according to the method of Cox et al (5) . The recalibrated mass errors were then averaged across all high-confidence spectra identified in order to calculate a given peptide's AMD.
An examination of V gene sequences suggested that isobaric peptides with an isoleucineleucine swap were more common than in standard proteomes and thus required special ! 7! consideration, as two peptides differing exclusively in this way will generate identical spectra by MS and cannot be differentiated. We therefore considered all Iso/Leu sequence variants as a single group, and mapped the group to all CDRH3s associated with any of the group members, which preserved the possibility that even if an individual sequence cannot be uniquely identified, the associated CDRH3 might still be unique. For other isobaric pairings (e.g., Asp/Gly-Gly, Gln/Gly-Ala) and ambiguous identifications where MS/MS spectral differences can distinguish between pairings, we considered only the top-ranked PSM as determined by the SEQUEST-Percolator pipeline.
Multiple V H sequence alignment
Multiple sequence alignments of the iCDRH3 sequences with the V gene database were carried out using MUSCLE (6) as implemented in Geneious (www.geneious.com). Full V H sequences with the highest iCDRH3 counts were chosen if the number of reads for the sequence was higher compared to the next sequence in the alignment.
Pairwise sequence alignments for every potential pairing of CDRH3 sequences, were calculated using the Needleman-Wunsch global alignment algorithm (7). Sequences were then clustered using complete linkage hierarchical clustering employing the pairwise alignment scores as the distance measures. The sequences were organized into a dendrogram in which the maximum number of mutations found in each cluster at each cluster level was determined and plotted as the y-axis (Fig. 3a and Fig. S7 for CCH and BSA rabbits respectively).
Construction of synthetic antibody genes.
CCH rabbit: Synthetic gene construction was carried out as described previously (1) with the following modifications: The coding sequences for the selected V H genes were designed using the GeneFab software component of our in-house protein fabrication ! 8! automation (PFA) platform (8). After reverse translation of the primary amino acid sequences for each V H using an E. coli class II codon table for CCH rabbit, the coding sequences were built with a polyglycine-serine linker (GGGGS) 2 at the C-terminus for overlap reassembly scFv construction. A 5' SfiI restriction endonuclease site was added to facilitate cloning of the scFv constructs into the pAK200 phage display vector (9). The V H genes were aligned using the sequence encoding the common (GGGGS) 2 linker sequence and a universal randomly generated stuffer sequence was applied to the ends of the V H sequences to ensure that all of the constructs were of the same length. The Sfi I-V H-(GGGGS) 2 genes were synthesized from overlapping oligonucleotides using a modified thermodynamically balanced inside-out nucleation PCR (10 Both elution fractions (700 µl and the residual 250 µl) were used to infect 12 ml of log phase E.coli XL1-Blue or Jude1 cells, with 3 ml of the culture placed in the neutralized immunotubes to capture remaining bound phage. After 1 hour at 37 °C, the infected culture was plated onto LB agar plates containing chloramphenicol (35 µg/ml) + 1% w/v glucose for titering both the BSA-specific elution and the CCH-specific elution. For the CCH libraries, selectivity was determined as the titer of the CCH-specific elution divided by the titer of the BSA-specific elution (Table S4 ) and for the BSA libraries the selectivity was determined against the 2% milk elution. The entire CCH-specific and BSA-specific elution solutions (~12 ml infected culture spun down and resuspended in 2 ml 2YT) were spread onto large LB-chloramphenicol-glucose plates and incubated overnight 37 °C. Colonies were scraped and cells were resuspended and used for subsequent rounds of phage amplification and panning.
Phage scFv ELISAs
To evaluate Fig. S12 . Rarefaction analysis (subsampling and interpolation) and species richness analysis (extrapolation) of the CDRL3 repertoire in rabbit CCH. The rarefaction analysis was completed using the Vegan package(14)! as implemented in the statistical environment R, by subsampling ~30,000 reads at 1000 read increments. A Chao (15) estimate of 10,252 unique CDRL3 sequences represents the estimated CDRL3 repertoire size. Species richness estimation was used to determine the number of clones that the libraries require to sample >99% of all unique CDRL3. This analysis showed that a library size of ~10 6 would be sufficient to capture >99% of the asymptotic estimate of CDRL3 diversity.
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